| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |